Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review

Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review

The scarcity of novel and effective therapeutics for the treatment of cancer is a pressing and alarming issue that needs to be prioritized. The number of cancer cases and deaths are increasing at a rapid rate worldwide. Doxorubicin, an anticancer agent, is currently used to treat several types of ca...

Full description

Bibliographic Details
Main Authors: Sijongesonke Peter, Sibusiso Alven, Rejoice Bethusile Maseko, Blessing Atim Aderibigbe
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Molecules
Subjects:
cancer
doxorubicin
hybrid compounds
drug resistance
drug toxicity
chemotherapeutic drugs
Online Access:https://www.mdpi.com/1420-3049/27/14/4478

Internet

https://www.mdpi.com/1420-3049/27/14/4478

Similar Items